Angeliq (Bayer HealthCare Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Angeliq drug offered from Bayer HealthCare Pharmaceuticals Inc.. This Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bayer HealthCare Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | drospirenone and estradiol |
| SUBSTANCE NAME: | ESTRADIOL; DROSPIRENONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-02-29 |
| END MARKETING DATE: | 0000-00-00 |
Angeliq HUMAN PRESCRIPTION DRUG Details:
| Item Description | Angeliq from Bayer HealthCare Pharmaceuticals Inc. |
| LABELER NAME: | Bayer HealthCare Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .5; .25(mg/1; mg/1) |
| START MARKETING DATE: | 2012-02-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50419-482_6d15eb36-1591-4da2-9055-e2518eff570d |
| PRODUCT NDC: | 50419-482 |
| APPLICATION NUMBER: | NDA021355 |
Other ESTRADIOL; DROSPIRENONE Pharmaceutical Manufacturers / Labelers:
